53 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00833 | AAP-H | YVPGP | Marine invertebrates | Apoptosis inducing | MTT assay | DU-145 | Prostate cancer | IC50 : 9.605 mM |
| dbacp00834 | AAP-H | YVPGP | Marine invertebrates | Apoptosis inducing | MTT assay | DU-146 | Prostate cancer | IC50 : 7.910 mM |
| dbacp00835 | AAP-H | YVPGP | Marine invertebrates | Apoptosis inducing | MTT assay | DU-147 | Prostate cancer | IC50 : 2.298 mM |
| dbacp01589 | BCP-A | WPP | Marine invertebrates | Inducing apoptosis | Not specified | PC-3 | Not specified | IC50 : 1.99 mg/ml |
| dbacp01590 | BCP-A | WPP | Marine invertebrates | Inducing apoptosis | Not specified | DU-145 | Not specified | IC50 : 2.80 mg/ml |
| dbacp01591 | BCP-A | WPP | Marine invertebrates | Inducing apoptosis | Not specified | H1299 | Not specified | IC50 : 3.3 mg/ml |
| dbacp01592 | BCP-A | WPP | Marine invertebrates | Inducing apoptosis | Not specified | HeLa | Not specified | IC50 : 2.54 mg/ml |
| dbacp02580 | CS5931 | MVVCPDGQSECPDGN | Marine invertebrates | Inducing apoptosis | Not specified | HCT-8 | Colorectal cancer | Not found |
| dbacp03034 | Galaxamide derivative (Compound 3) | cyclo(WnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Breast cancer | IC50 : 3.98 ± 0.71 μg/mL |
| dbacp03035 | Galaxamide derivative (Compound 3) | cyclo(WnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MCF-7 | Breast cancer | IC50 : 1.72 ± 0.85 μg/mL |
| dbacp03036 | Galaxamide derivative (Compound 3) | cyclo(WnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Breast cancer | IC50 : 5.32 ± 0.42 μg/mL |
| dbacp03037 | Galaxamide derivative (Compound 3) | cyclo(WnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MD-MBA-231 | Breast cancer | IC50 :3.51 ± 1.32 μg/Ml |
| dbacp03038 | Galaxamide derivative Compound 1 | cyclo(FnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Breast cancer | IC50 : 6.25 ± 1.03 μg/mL |
| dbacp03039 | Galaxamide derivative Compound 1 | cyclo(FnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MCF-7 | Breast cancer | IC50 : 4.76 ± 1.36 μg/mL |
| dbacp03040 | Galaxamide derivative Compound 1 | cyclo(FnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Breast cancer | IC50 : 13.22 ± 1.12 μg/mL |
| dbacp03041 | Galaxamide derivative Compound 1 | cyclo(FnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MD-MBA-231 | Breast cancer | IC50 : 5.83 ± 0.45 μg/M |
| dbacp03042 | Galaxamide derivative Compound 2 | cyclo(NAl-nMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Breast cancer | IC50 : 8.42 ± 1.82 μg/mL |
| dbacp03043 | Galaxamide derivative Compound 2 | cyclo(NAl-nMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MCF-7 | Breast cancer | IC50 : 3.16 ± 0.92 μg/mL |
| dbacp03044 | Galaxamide derivative Compound 2 | cyclo(NAl-nMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Breast cancer | IC50 : 6.43 ± 1.20 μg/mL |
| dbacp03045 | Galaxamide derivative Compound 2 | cyclo(NAl-nMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MD-MBA-231 | Breast cancer | IC50 : 4.48 ± 2.24 μg/mL |
| dbacp04317 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Cervical cancer | Not found |
| dbacp04318 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Esophageal cancer | Not found |
| dbacp04319 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Liver cancer | Not found |
| dbacp04320 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Bladder cancer | Not found |
| dbacp04321 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EC109 | Cervical cancer | Not found |
| dbacp04322 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EC109 | Esophageal cancer | Not found |
| dbacp04323 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EC109 | Liver cancer | Not found |
| dbacp04324 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EC109 | Bladder cancer | Not found |
| dbacp04325 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Cervical cancer | Not found |
| dbacp04326 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Esophageal cancer | Not found |
| dbacp04327 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Liver cancer | Not found |
| dbacp04328 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Bladder cancer | Not found |
| dbacp04329 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EJ | Cervical cancer | Not found |
| dbacp04330 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EJ | Esophageal cancer | Not found |
| dbacp04331 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EJ | Liver cancer | Not found |
| dbacp04332 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EJ | Bladder cancer | Not found |
| dbacp04333 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | THLE-3 | Cervical cancer | Not found |
| dbacp04334 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | THLE-3 | Esophageal cancer | Not found |
| dbacp04335 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | THLE-3 | Liver cancer | Not found |
| dbacp04336 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | THLE-3 | Bladder cancer | Not found |
| dbacp05089 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | HT-29 | Colorectal cancer | Not found |
| dbacp05090 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | DLD-1 | Colorectal cancer | Not found |
| dbacp05091 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | HCT116 | Colorectal cancer | Not found |
| dbacp05092 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | SW-620 | Colorectal cancer | Not found |
| dbacp05093 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | L02 | Colorectal cancer | Not found |
| dbacp05244 | Pentapeptide (ILYMP) | ILYMP | Marine invertebrates | Inducing apoptosis | MTT assay | DU-145 | Prostate cancer | IC50 :11.25 mM |
| dbacp06024 | SCAP1 | LANAK | Marine invertebrates | Inducing apoptosis | Not specified | HT-29 | Not specified | IC50 : 90.31 ± 0.45 μM |
| dbacp06025 | SCAP1 | LANAK | Marine invertebrates | Inducing apoptosis | Not specified | HT-29 | Not specified | IC50 : 70.87 ± 0.82 μM |
| dbacp06026 | SCAP1 | LANAK | Marine invertebrates | Inducing apoptosis | Not specified | HT-29 | Not specified | IC50 : 60.21 ± 0.45 μM |
| dbacp06027 | SCH-P10 | DYVP | Marine invertebrates | Inducing apoptosis | MTT assay | DU-145 | Prostate cancer | IC50 : 1.21 mg/mL |
| dbacp06028 | SCH-P10 | DYVP | Marine invertebrates | Inducing apoptosis | MTT assay | PC-3 | Prostate cancer | IC50 : 1.09 mg/mL |
| dbacp06029 | SCH-P9 | LPGP | Marine invertebrates | Inducing apoptosis | MTT assay | DU-145 | Prostate cancer | IC50 : 1.21 mg/mL |
| dbacp06030 | SCH-P9 | LPGP | Marine invertebrates | Inducing apoptosis | MTT assay | PC-3 | Prostate cancer | IC50 : 1.09 mg/mL |